|
Market Closed -
Nasdaq
00:00:00 29/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.770 USD | -1.07% |
|
-3.48% | -24.32% |
| 08-14 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 92.38M | - | - | - | ||
| 79.3B | |||||
| 59.21B | |||||
| 55.09B | - | ||||
| 49.86B | |||||
| 47.9B |
Select your edition
All financial news and data tailored to specific country editions
